Can semaglutide slow aging?
Key claim: Attia reports that a new study found semaglutide extended median lifespan and improved several aging measures in female mice, while cautioning that the headline requires careful interpretation.
Abstract
A new study found that semaglutide extended median lifespan and improved several measures of aging in female mice—but the headline requires careful interpretation. The post Can semaglutide slow aging? appeared first on Peter Attia MD.
Why this matters
A high-reach longevity communicator amplifying a single-sex mouse lifespan result is exactly the moment where trend momentum can outrun evidence: the underlying study is animal-model tier, but audience uptake will treat semaglutide as a validated geroprotector. Tracking how Attia frames the caveats — versus how the claim propagates downstream — is the consumer-protection signal here.